{"disease":{"id":"nasal-polyp","name":"Nasal polyp","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":11},"drugs":{"marketed":[{"drug_id":"tezepelumab","indication_name":"Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tezspire","generic_name":"TEZEPELUMAB","company_name":"AstraZeneca / Amgen","drug_phase":"marketed","molecular_target":"","drug_class":"Thymic Stromal Lymphopoietin Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"beclometasone-dipropionate","indication_name":"Nasal polyp","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Beconase Aq","generic_name":"beclometasone dipropionate","company_name":"","drug_phase":"marketed","molecular_target":"Probable G-protein coupled receptor 97","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"rhinocort","indication_name":"Nasal polyp","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rhinocort","company_name":"Marinomed Biotech AG","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"beclometasone","indication_name":"Nasal polyp","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Beclometasone","company_name":"Imperial College London","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"rimegepant-75-mg","indication_name":"Acute treatment of chronic rhinosinusitis with and without nasal polyps","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75 MG","generic_name":"rimegepant-75-mg","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist (gepant)","quality_score":25,"revenue":null,"mechanism":"Rimegepant selectively antagonizes the calcitonin gene-related peptide (CGRP) receptor to block migraine pain signaling."}],"offLabel":[],"totalMarketed":4,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03694847","title":"Asthma With Nasal Polyposis","phase":"","overall_status":"COMPLETED","enrollment_count":1293,"lead_sponsor_name":"Louis-Philippe Boulet","has_results":false},{"nct_id":"NCT06231004","title":"Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06970977","title":"CRS Questionnaire Validation Project","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The European Forum for Research and Education in Allergy and Airway Diseases","has_results":false},{"nct_id":"NCT06501807","title":"BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":900,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT04959448","title":"Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":717,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05529784","title":"Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05056714","title":"Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score)","phase":"","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"Centre Hospitalier Intercommunal Creteil","has_results":false},{"nct_id":"NCT02898454","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT04851964","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03085797","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":414,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03401229","title":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":413,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07424144","title":"An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":380,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04998604","title":"EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT07200336","title":"Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT07125586","title":"Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":353,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT01624662","title":"Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Optinose US Inc.","has_results":true},{"nct_id":"NCT01622569","title":"Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Optinose US Inc.","has_results":true},{"nct_id":"NCT07290140","title":"Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Airiver Medical, Inc.","has_results":false},{"nct_id":"NCT04157335","title":"Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":295,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06013241","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Insmed Incorporated","has_results":false},{"nct_id":"NCT05274750","title":"Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02912468","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05180357","title":"RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.","phase":"","overall_status":"COMPLETED","enrollment_count":273,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05281523","title":"Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05248997","title":"Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03478930","title":"An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07520162","title":"A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05942222","title":"A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07420257","title":"A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":212,"lead_sponsor_name":"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06834360","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06834347","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06362122","title":"Anatomo-clinico-biological Profiles in Severe Nasal Polyps","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT07446738","title":"A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06118554","title":"3D Printing to Improve Nasal Irrigation Outcome","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT06258772","title":"Mepolizumab in the Treatment of Patients With Severe Uncontrolled CRSwNP: a Multicentric Real Life Observational Study","phase":"","overall_status":"UNKNOWN","enrollment_count":199,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07498374","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT05436275","title":"A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT05938972","title":"Real Life Study of Biologicals in Patients With Severe CRSwNP","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT06706817","title":"A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04607005","title":"Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00731185","title":"Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT05598424","title":"CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06393946","title":"Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07313917","title":"A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT05649813","title":"A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region","phase":"","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06776042","title":"Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT03280550","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07187583","title":"Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05626257","title":"Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03280537","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}